Health News

Health News

The health headlines move fast and most coverage gets the science wrong. Every day, Dr. Ravi Kumar, MD, a board-certified neurosurgeon, cuts through the noise: what a new study or story actually says, what it doesn’t, and what it means for you. Researched, sourced, and reviewed before it’s published.

An unopened white cardboard mailer resting on a kitchen counter next to a stack of unread letters in morning light

Stool test tied to 43% fewer colon cancer deaths

A 376,511-person Swedish cohort found that people who returned their mailed stool kit had 43% lower colorectal cancer mortality, while everyone who was merely invited had 26% lower mortality, and the difference between those two numbers is behavior, not biology.

Health workers in white protective suits and face shields walking toward a tented field clinic on a dirt road under an overcast sky

Congo Ebola outbreak tops 5,000 cases with no proven vaccine

The Democratic Republic of the Congo has reported 5,290 confirmed Bundibugyo virus cases and 2,516 deaths in the largest and fastest-growing Ebola outbreak ever recorded, and the one licensed Ebola vaccine was built against a different species.

A gloved researcher holding a small clear culture dish of living cells under warm laboratory light, with stainless steel surgical instruments arranged on a tray softly out of focus behind

Lab-grown heart cells pass first randomized safety test

A 20-patient randomized trial in Nature Medicine found no tumors and no sustained ventricular tachycardia after injecting lab-grown human heart muscle cells during bypass surgery, but every patient who got the cells developed an abnormal rhythm within a month.

Gloved hands arranging small amber medication bottles on a bright clinic counter in soft natural daylight

Chemo-free combo stalled metastatic breast cancer 25 months

In the 29-patient ASPIRE trial, anastrozole, palbociclib, trastuzumab and pertuzumab held advanced breast cancer in check for a median of nearly 25 months without any chemotherapy, though 62 percent of patients still had a severe side effect.

A gloved laboratory scientist holding a small clear glass vial up to soft daylight in a bright modern lab

mRNA cancer vaccine delays melanoma return in phase 3 trial

Merck and Moderna say their personalized mRNA vaccine plus Keytruda delayed melanoma recurrence in 1,137 patients after surgery, the first positive phase 3 result for an mRNA cancer therapy, though no effect sizes have been released.

Person doing gentle yoga stretches on a mat in a sunlit living room with warm wood floors and soft natural light

Lumbar belt beat usual care for low back pain in trial

A 168-patient French randomized trial found that adding a soft lumbar belt to usual care improved disability and pain more than usual care alone, and cut the share of patients using pain medication from 67.6% to 50.6%.

A smartphone lying face up on a wooden table showing a bright colorful social media feed, with a blurred living room in the background

Half of delta-8 Instagram posts use youth appeals

A content analysis of 837 Instagram posts from the nine leading intoxicating hemp brands found youth-oriented imagery in 49.6% and health or age warnings in 2.5%, weeks before a federal ban on these products is scheduled to start.

Gloved hand holding a labeled blood collection tube beside a rack of samples on a clinic bench in soft daylight

Only 27% of US adults are immune to hepatitis B

A new NHANES analysis of 13,514 adults found that serologic protection against hepatitis B and hepatitis A is lowest in the patients who need it most, four years after the vaccine was recommended for every adult under 60.